Shubulade Smith
#72,380
Most Influential Person Now
British academic and consultant psychiatrist
Shubulade Smith's AcademicInfluence.com Rankings
Download Badge
Biology
Shubulade Smith's Degrees
- PhD Psychiatry University of Oxford
Why Is Shubulade Smith Influential?
(Suggest an Edit or Addition)According to Wikipedia, Shubulade Smith is a British academic and consultant psychiatrist at the South London and Maudsley NHS Foundation Trust . She is a senior lecturer at King's College, London and Clinical Director at the NCCMH and forensic services at SLaM, and is .
Shubulade Smith's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Sexual dysfunction in patients taking conventional antipsychotic medication (2002) (252)
- The WPA-Lancet Psychiatry Commission on the Future of Psychiatry. (2017) (245)
- Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia (2004) (206)
- An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode Psychosis (2017) (180)
- The Effects of Antipsychotic-Induced Hyperprolactinaemia on the Hypothalamic-Pituitary-Gonadal Axis (2002) (177)
- A well-being programme in severe mental illness. reducing risk for physical ill-health: A post-programme service evaluation at 2 years (2007) (94)
- Ethnic variations in compulsory detention under the Mental Health Act: a systematic review and meta-analysis of international data (2019) (94)
- Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder. (2007) (90)
- Vitamin D deficiency in first episode psychosis: A case–control study (2013) (84)
- Antipsychotics and hyperprolactinaemia: Clinical recommendations (2008) (83)
- Gender differences in antipsychotic prescribing (2010) (67)
- Bone Mineral Density and Its Relationship to Prolactin Levels in Patients Taking Antipsychotic Treatment (2005) (64)
- What you don't know won't hurt you: Information given to patients about the side-effects of antipsychotic drugs (2000) (57)
- Drugs that cause sexual dysfunction. (2004) (57)
- Sedentary behaviour is associated with elevated C-reactive protein levels in people with psychosis (2015) (48)
- Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics (2008) (48)
- Sexual dysfunction in people with prodromal or first-episode psychosis (2012) (45)
- Effects of Antipsychotics on Sexual and Endocrine Function in Women: Implications for Clinical Practice (2003) (39)
- Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in established psychosis (IMPaCT) (2017) (34)
- Racial stereotyping: survey of psychiatrists in the United Kingdom (2001) (32)
- Improving physical health and reducing substance use in psychosis – randomised control trial (IMPACT RCT): study protocol for a cluster randomised controlled trial (2013) (30)
- Sexual health risk reduction interventions for people with severe mental illness: a systematic review (2015) (28)
- Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study (2019) (23)
- The impact of hyperprolactinaemia on sexual function in patients with psychosis (2008) (23)
- The Representativeness of Participants With Severe Mental Illness in a Psychosocial Clinical Trial (2018) (22)
- Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites? (2014) (22)
- Hyperprolactinaemia caused by antipsychotic drugs (2002) (21)
- Schizophrenia as segmental progeria (2011) (21)
- Pain is independently associated with reduced health related quality of life in people with psychosis (2015) (18)
- Tobacco smoking and nicotine dependence in first episode and established psychosis. (2019) (17)
- Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom (2020) (16)
- Vitamin D and clinical symptoms in First Episode Psychosis (FEP): A prospective cohort study (2019) (14)
- The Relationship Between Prolactin Levels and Glucose Homeostasis in Antipsychotic-treated Schizophrenic Patients (2006) (13)
- Mental health review tribunal medical reports (1998) (12)
- Reasons behind the rising rate of involuntary admissions under the Mental Health Act (1983): Service use and cost impact. (2020) (11)
- Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotion (2017) (10)
- Understanding increasing rates of psychiatric hospital detentions in England: development and preliminary testing of an explanatory model (2020) (9)
- Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial (2020) (7)
- Translation and cross-cultural adaptation of the Sexual Function Questionnaire (SFQ) into Brazilian Portuguese. (2017) (7)
- Sexuality in psychosis: dysfunction, risk and mental capacity (2011) (5)
- Dietary intake, physical activity and sedentary behaviour patterns in a sample with established psychosis and associations with mental health symptomatology (2021) (5)
- Outcome of a psychosocial health promotion intervention aimed at improving physical health and reducing alcohol use in patients with schizophrenia and psychotic disorders (MINT) (2019) (5)
- Validating a new virtual reality measure of community function in schizophrenia (2006) (5)
- A health promotion intervention to improve lifestyle choices and health outcomes in people with psychosis: a research programme including the IMPaCT RCT (2020) (5)
- Advancing mental health equality: a mapping review of interventions, economic evaluations and barriers and facilitators (2020) (5)
- Effect of Vitamin D Supplementation on Outcomes in People With Early Psychosis (2021) (5)
- Comment on Hyperprolactinaemia and antipsychotic therapy in schizophrenia (2004) (5)
- Alendronic acid for antipsychotic-related osteopenia. (2004) (4)
- Clozapine and COVID-19 (2020) (4)
- Prescribing for erectile dysfunction: A Delphi based consensus study (2005) (4)
- Multidisciplinary research priorities for the COVID-19 pandemic (2020) (4)
- Metabolic syndrome common in people with psychotic disorders, particularly in users of high potency antipsychotics (2008) (3)
- Effects of long-term prolactin-raising antipsychotic Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients medication on bone mineral density in patients (2004) (2)
- Physical health in patients with severe mental illness (2004) (2)
- Prevalence of HIV in mental health service users: a retrospective cohort study (2023) (1)
- The Future of Psychiatry Commission - Authors' reply. (2018) (1)
- The Maudsley antipsychotic medication review service guidelines (2003) (1)
- Predictive value of cardiometabolic biomarkers and depressive symptoms for symptom severity and quality of life in patients with psychotic disorders. (2021) (1)
- The NHS is not an island—tackling racial disparities in healthcare (2022) (1)
- Comments on "Prolactin levels and erectile function in patients treated with risperidone" (J Clin Psychopharmacol 2004;24:161-166). (2005) (1)
- The well being support programme: Basic nutritional advice in patients with Serious Mental Illness (SMI) (2004) (1)
- The association between social class and the impact of treatment for mental health problems: a systematic review and narrative synthesis (2022) (1)
- Risk assessment and risk management among severely mentally ill patients requiring hospitalisation (2012) (1)
- Poster #T127 CARDIOVASCULAR RISK FACTORS AND METABOLIC SYNDROME IN PEOPLE WITH SEVERE MENTAL ILLNESS – A UK CROSS–SECTIONAL STUDY (2014) (0)
- 24 – Gender and sexuality in psychiatry (2012) (0)
- Advance directives reduce friction over involuntary treatment. (2021) (0)
- Drugs that cause sexual dysfunction. (1987) (0)
- Poster #S216 VITAMIN D AS A PREDICTOR OF ILLNESS SEVERITY AT ONE YEAR IN FIRST EPISODE PSYCHOSIS (2014) (0)
- O5.2. PREDICTORS OF CARDIOMETABOLIC RISK IN THE YEAR AFTER ONSET OF PSYCHOSIS: A PROSPECTIVE COHORT STUDY (2018) (0)
- Poster #180 VITAMIN D DEFICIENCY IN FIRST EPISODE PSYCHOSIS (2012) (0)
- Sexual dysfunction and antipsychotic drugs (2004) (0)
- The Creation of Inter-Ethnic Images for Studies in Applied Psychology (2003) (0)
- Non-clinical bed-management strategies increase financial costs and readmission rates (2018) (0)
- The Patient and Carer Race Equality Framework: a model to reduce mental health inequity in England and Wales (2023) (0)
- Women and Psychiatric Treatment : A Comprehensive Text and Practical Guide (2013) (0)
- psychosis Sexual dysfunction in people with prodromal or first-episode (2012) (0)
- Variable practice complicates standard setting for PICU prescribing (2010) (0)
- Cost-effectiveness of IMPACT: a Health Promotion Intervention for People with Established Psychotic Illnesses (2015) (0)
- Vitamin D and cardiometabolic outcomes in first episode psychosis (FEP): A prospective cohort study (2022) (0)
- Non-clinical bed management strategies in psychiatry (2010) (0)
- Does environmental confounding mask pleiotropic effects of a multiple sclerosis susceptibility variant on vitamin D in psychosis? (2015) (0)
- Endocrine antipsychotic side-effects need to be systematically assessed (2018) (0)
- IMPaCT – MOTIVATING A CHANGE IN HEALTH BEHAVIOUR (2012) (0)
- Is prolactin responsible for glucoregulatory disturbance in patients taking antipsychotic treatment for schizophrenia (2006) (0)
- Hypogonadism with long-term antipsychotic medication (2000) (0)
- Work package 1: physical health and substance use in first episode of psychosis (PUMP) (2020) (0)
- Treating women with schizophrenia (2016) (0)
- 1 Ethnic variations in compulsory detention : a Systematic Review and Meta-Analysis of the international data (2019) (0)
- T183. LOW LEVELS OF VITAMIN D ARE ASSOCIATED WITH REDUCED CORTICAL THICKNESS AND SURFACE AREA IN FRONTAL, TEMPORAL AND OCCIPITAL REGIONS IN FIRST-EPISODE PSYCHOSIS PATIENTS (2020) (0)
- Rosiglitazone inhibits human mesangial cell proliferation in vitro (2000) (0)
This paper list is powered by the following services:
Other Resources About Shubulade Smith
What Schools Are Affiliated With Shubulade Smith?
Shubulade Smith is affiliated with the following schools:
